Addiction in pregnancy

Journal of Addictive Diseases

Volumn 29, Issue 2, 2010, Pages 175-191

  Keegan, Joan ^a   Parva, Mehdi ^a   Finnegan, Mark ^a   Gerson, Andrew ^a,b   Belden, Michael ^a  

^a LANKENAU HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Addiction; Alcohol; Amphetamines; Cocaine; Illicit drugs; Marijuana; Opiates; Pregnancy; Tobacco

Indexed keywords

ALCOHOL; AMPHETAMINE; ANXIOLYTIC AGENT; BARBITAL; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CANNABIS; CARBON MONOXIDE; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; DIHYDROMORPHINE; DRONABINOL; HALOTHANE; HYDRALAZINE; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; LABETALOL; METHADONE; NARCOTIC ANALGESIC AGENT; NICOTINE; NORADRENALIN; OPIATE; OXYCODONE; PHENOBARBITAL; PROPOFOL; SNAKE VENOM;

ADDICTION; ALCOHOL ABUSE; ANXIETY; BEHAVIOR DISORDER; BETA ADRENERGIC STIMULATION; BIRTH DEFECT; BODY MASS; BREAST MILK; CALORIC INTAKE; CHILD BEHAVIOR; CHILDHOOD DISEASE; COCAINE DEPENDENCE; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DOPPLER FLOWMETRY; DRUG MILK LEVEL; ECTOPIC PREGNANCY; FEEDING DISORDER; FETAL ALCOHOL SYNDROME; FETUS ECHOGRAPHY; FETUS HEART; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; INTERPERSONAL COMMUNICATION; INTRAUTERINE GROWTH RETARDATION; LABOR MANAGEMENT; LETHARGY; LOW BIRTH WEIGHT; MATERNAL CARE; MATERNAL NUTRITION; MATERNAL SMOKING; MENTAL DEFICIENCY; METHADONE TREATMENT; MIGRAINE; NEWBORN CARE; NORADRENALIN BLOOD LEVEL; OPIATE ADDICTION; PLACENTA INSUFFICIENCY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PRESCRIPTION; PUERPERIUM; RELAPSE; RESPIRATORY TRACT DISEASE; REVIEW; SCREENING; SEIZURE; SEXUALLY TRANSMITTED DISEASE; SMOKING CESSATION; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; SUBSTANCE ABUSE; TERATOGENICITY; TOBACCO; WITHDRAWAL SYNDROME;

BEHAVIOR, ADDICTIVE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FEMALE; HUMANS; NARCOTICS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; SMOKING; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 77951447067     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550881003684723     Document Type: Review

References (63)

1. Kuczkowski KM. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007; 19:578-585
2. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National findings (DHHS Publication No. SMA 03- 3836, NSDUH Series H-22). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2003. [Available at http://www.oas.samhsa.gov/p0000016. htm#2k2].
3. IARC (International Agency for Research on Cancer) Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83:1-1438.
4. Spitzer WO, Lawrence V, Dales R, Hill G, Archer MC, Clark P, Abenhaim L, Hardy J, Sampalis J, Pinfold SP, et al. Links between passive smoking and disease: a best-evidence synthesis. A report of theWorking Group on Passive Smoking. Clin Invest Med 1990; 13:17-42.
5. National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control. Ann Intern Med 2006; 145:839-844.
6. Kandel DB, Griesler PC, Schaffran C. Educational attainment and smoking among women: risk factors and consequences for offspring. Drug Alcohol Depend 2009; 104(Suppl 1):S24-33.
7. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004:CD001055.
8. Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol 2009; 65:325-330
9. Goodwin RD, Keyes K, Simuro N.Mental disorders and nicotine dependence among pregnant women in the United States. Obstet Gynecol 2007; 109:875-883
10. Thielen A, Klus H, Muller L. Tobacco smoke: unraveling a controversial subject. Exp Toxicol Pathol 2008; 60:141-156
11. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000; 5:231-241
12. Crawford JT, Tolosa JE, Goldenberg RL. Smoking cessation in pregnancy: why, how, and what next. Clin Obstet Gynecol 2008; 51:419-435
13. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of nonsmokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989; 96:907-915
14. Fanslow J, Silva M, Robinson E, Whitehead A. Violence during pregnancy: associations with pregnancy intendedness, pregnancy-related care, and alcohol and tobacco use among a representative sample of New Zealand women. Aust N Z J Obstet Gynaecol 2008; 48:398-404.
15. Rosenberg L, Mitchell AA, Shapiro S, Slone D. Selected birth defects in relation to caffeine-containing beverages. JAMA 1982; 247:1429-1432
16. Chavarro JE, Rich-Edwards JW, Rosner BA,Willett WC. Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology 2009; 20(3):374-381
17. Weng X, Odouli R, Li DK. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008; 198:279 e1-8.
18. Hadeed A, Siegel S. Newborn cardiac arrhythmias associated with maternal caffeine use during pregnancy. Clin Pediatr (Phila) 1993; 32:45-47
19. Briggs G, Freeman R, Yaffe J. Drugs in pregnancy and lactation. Philadelphia: LippincottWilliams&Wilkins, 2008.
20. Floyd RL, Jack BW, Cefalo R, Atrash H, Mahoney J, Herron A, Husten C, Sokol RJ. The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures. Am J Obstet Gynecol 2008; 199:S333-9.
21. Chang G. Alcohol-screening instruments for pregnant women. Alcohol Res Health 2001; 25:204-209
22. Creasy RK, Resnik R, Iams JD. Creasy and Resnik's maternal-fetal medicine : principles and practice. Philadelphia, PA: Saunders/Elsevier, 2009.
23. Fleming MF, Lund MR, Wilton G, Landry M, Scheets D. The Healthy Moms Study: the efficacy of brief alcohol intervention in postpartum women. Alcohol Clin Exp Res 2008; 32:1600-1606
24. Minozzi S, Amato L, Vecchi S, Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 2008:CD006318.
25. Rettig R. Federal Regulation of Methadone: Table of Contents and Executive Summary.Washington, DC: National Academy Press, 1995.
26. Food and Drug Administration. Labelling and prescription drug advertising:content and format for labelling for human prescription drug. Fed Reg 1980; 44:37434-37467
27. NSDUH. Substance Abuse and Mental Health Administration. Results form the 2005 National Survey on Drug Use and Health: National Findings. In: Office of Applied Studies, NSH- Ed. Rockville, MD: DHHS, 2006.
28. Schempf AH, Strobino DM. Illicit drug use and adverse birth outcomes: is it drugs or context? J Urban Health 2008; 85:858-873
29. Muhuri PK, Gfroerer JC. Substance use among women: associations with pregnancy, parenting, and race/ethnicity. Matern Child Health J 2009; 13:376-385
30. Bhuvaneswar CG, Chang G, Epstein LA, Stern TA. Cocaine and opioid use during pregnancy: prevalence and management. Prim Care Companion J Clin Psychiatry 2008; 10:59-65.
31. Bateman DA, Chiriboga CA. Dose-response effect of cocaine on newborn head circumference. Pediatrics 2000; 106:E33.
32. Vidaeff AC, Mastrobattista JM. In utero cocaine exposure: a thorny mix of science and mythology. Am J Perinatol 2003; 20:165-172
33. Bauer CR, Langer JC, Shankaran S, BadaHS, Lester B, Wright LL, Krause-Steinrauf H, Smeriglio VL, Finnegan LP,Maza PL,Verter J. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr AdolescMed 2005; 159:824-834
34. Minnes S, Singer LT, Humphrey-Wall R, Satayathum S. Psychosocial and behavioral factors related to the post-partum placements of infants born to cocaine-using women. Child Abuse Negl 2008; 32:353-366
35. Cox S, Posner SF, Kourtis AP, Jamieson, DJ. Hospitalizations with amphetamine abuse among pregnant women. Obstet Gynecol 2008; 111:341-347
36. Zapata LB, Hillis SD, Marchbanks PA, Curtis KM, Lowry R. Methamphetamine use is independently associated with recent risky sexual behaviors and adolescent pregnancy. J Sch Health 2008; 78:641-648
37. Wouldes T, LaGasse L, Sheridan J, Lester B. Maternal methamphetamine use during pregnancy and child outcome: what do we know? N Z Med J 2004; 117: U1180.
38. Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O'Keeffe M, Thomas SH. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. Eur J Clin Pharmacol 2004; 60:635-641
39. Werler MM, Sheehan JE, Mitchell AA. Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology 2003; 14:349-354
40. Thomas DB. Cleft palate, mortality and morbidity in infants of substance abusing mothers. J Paediatr Child Health 1995; 31:457-460
41. Bays J. Fetal vascular disruption with prenatal exposure to cocaine or methamphetamine. Pediatrics 1991; 87:416-418
42. Nora JJ, Vargo TA, Nora AH, Love KE, McNamara DG. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1970; 1:1290-1291
43. Heinonen OP, Sloan D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group Inc., 1977.
44. Little BB, Snell LM, Gilstrap LC 3rd. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988; 72:541-544
45. Milkovich L, van der Berg BJ. Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol 1977; 129:637-642
46. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning,W, Strauss A, Della Grotta S, Liu J, Lester BM. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118:1149-1156
47. Naeye RL. Maternal use of dextroamphetamine and growth of the fetus. Pharmacology 1983; 26:117-120
48. Ramin SM, Little BB, Trimmer KJ, Standard DI, Blakely CA, Snell LM. Methamphetamine use during pregnancy. Am J Obstet Gynecol 1992; 166:353.
49. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111:571-578
50. Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 2003; 24:17-23.
51. Skelton MR, Williams MT, Vorhees CV. Developmental effects of 3,4-methylenedioxymethamphetamine: a review. Behav Pharmacol 2008; 19:91-111.
52. Abel EL, Sokol RJ. Marijuana and cocaine use during pregnancy. Philadelphia: Lea & Febiger, 1988.
53. Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Phila County, Florida. N Engl J Med 1990; 322: 1202.
54. National Institute on Drug Abuse (NIDA) Research Report Series: Marijuana Abuse. July 2005. NIH Publication Number 05-3859.
55. Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth.AmJ Epidemiol 1986; 124:986-993
56. Greenland S, Richwald GA, Honda GD. The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population. Drug Alcohol Depend 1983; 11:359-366
57. Linn S, Schoenbaum SC, Monson RR, Rosner R, Stubblefield PC, Ryan KJ. The association of marijuana use with outcome of pregnancy. Am J Public Health 1983; 73:1161-1164 (Pubitemid 13001205)
58. Shiono PH, Klebanoff MA, Nugent RP, Cotch MF, Wilkins DG, Rollins DE, Carey JC, Behrman RE. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol 1995; 172:19-27.
59. American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care, Sixth Edition. Atlanta, GA: ACOG, 2007.
60. Byrne MW, Lerner HM. Communicating with addicted women in labor. MCN Am J Matern Child Nurs 1992; 17:22-26
61. Kuczkowski KM. Labor analgesia for the tobacco and ethanol abusing pregnant patient: a routine management? Arch Gynecol Obstet 2005; 271:6-10.
62. Ludlow J, Christmas T, Paech MJ, Orr B. Drug abuse and dependency during pregnancy: anaesthetic issues. Anaesth Intensive Care 2007; 35:881-893
63. Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth 2003; 15(5):382-394